Stifel Maintains Buy on DexCom, Raises Price Target to $95

Benzinga Newsdesk www.benzinga.com Positive 74.8%

Neg 0% Neu 0% Pos 74.8%

Stifel analyst Jonathan Block maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $90 to $95.

Comments

No comments yet. Be the first!